This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
The new frontline therapy is the first in a decade intended to treat aggressive pancreatic adenocarcinoma.
